(Q37420072)

20 August 2017

1 reference

title

Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future (English)

1 reference

20 August 2017

0 references

1 reference

bronchiolitis obliterans

1 reference

Eric J Grossman

1

1 reference

20 August 2017

Rebecca A Shilling

series ordinal

2

1 reference

20 August 2017

publication date

12 February 2009

1 reference

20 August 2017

published in

Translational Research

1 reference

20 August 2017

volume

153

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

153-165

1 reference

FUNCTIONS OF A TRANSPLANTED KIDNEY.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report--2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Mechanisms of airway obliteration after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Lung transplantation: opportunities for research and clinical advancement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Human and murine obliterative bronchiolitis in transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Analysis of risk factors for the development of bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Intermediate-term results after en bloc double-lung transplantation with bronchial arterial revascularization. Bordeaux Lung and Heart-Lung Transplant Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

The effect of primary graft dysfunction on survival after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Anti-Type V Collagen Lymphocytes that Express IL-17 and IL-23 Induce Rejection Pathology in Fresh and Well-Healed Lung Transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Lung transplantation in the rat: I. Technique and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Lung transplantation in the rat: II. lung perfusion scintigraphy in normal and left lung-transplanted rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Lung transplantation in the rat. III. Functional studies in iso- and allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Lung transplantation in the Fischer 344-->Wistar Kyoto rat strain combination is not suitable to study bronchiolitis obliterans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Obliterative bronchiolitis develops in miniature swine transplanted across a minor histocompatibility barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Orthotopic tracheal transplantation in the murine model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

A novel model for post-transplant obliterative airway disease reveals angiogenesis from the pulmonary circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Allograft airway fibrosis in the pulmonary milieu: a disorder of tissue remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

A mouse model of orthotopic vascularized aerated lung transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Specificity of T-cell alloreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Direct and indirect antigen recognition: the pathways to allograft immune rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Pathways of allorecognition: implications for transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

The importance of the indirect pathway of allorecognition in clinical transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

A role for indirect allorecognition in lung transplant recipients with obliterative bronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Trachea allograft class I molecules directly activate and retain CD8+ T cells that cause obliterative airways disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Expression of class II major histocompatibility complex antigens by bronchial epithelium in rat lung allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Lung immunogenicity, rejection, and obliterative bronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

A novel pathway of alloantigen presentation by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Pathogen recognition and innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

The role of hyaluronan degradation products as innate alloimmune agonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

TLR engagement prevents transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Toll-like receptor 4 mediates lung ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Innate immunity influences long-term outcomes after human lung transplant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Differentiation and function of Th17 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Risk factors for bronchiolitis obliterans: a systematic review of recent publications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Toll-like receptor signaling in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Innate immune control of pulmonary dendritic cell trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Human dendritic cells and transplant outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Pulmonary dendritic cells in local immunity to inert and pathogenic antigens in the respiratory tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

T helper cell effector fates--who, how and where?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Blocking the CD28-B7 T-cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Dependence of murine obstructive airway disease on CD40 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type1-dominated immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Further evidence that NK cells may contribute to the development of cardiac allograft vasculopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Mast cells are essential intermediaries in regulatory T-cell tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Molecular mechanisms of chronic rejection following transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Oligoclonal CD4(+) T cell expansions in lung transplant recipients with obliterative bronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Animal models for bronchiolitis obliterans syndrome following human lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Immune cells in a mouse airway model of obliterative bronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Immunological link between primary graft dysfunction and chronic lung allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

The biological functions of T helper 17 cell effector cytokines in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Immune therapies of autoimmune diseases: are we approaching a real cure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Airway epithelial cell damage mediated by antigen-specific T cells: implications in lung allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Pathologic pulmonary alterations in long-term human heart-lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

The role of respiratory epithelium in a rat model of obliterative airway disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Vascular endothelial growth factor expression and cyclosporine toxicity in renal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Role of platelet-derived growth factor and vascular endothelial growth factor in obliterative airway disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Bronchiolitis obliterans following haematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

A new murine model for bronchiolitis obliterans post-bone marrow transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.005

10.1016/J.TRSL.2009.01.005

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference